Prime Capital Investment Advisors’s United Therapeutics UTHR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$649K Sell
1,094
-25
-2% -$12.4K 0.01% 609
2025
Q4
$545K Sell
1,119
-103
-8% -$48K 0.01% 625
2025
Q3
$512K Buy
1,222
+19
+2% +$6.39K 0.01% 629
2025
Q2
$346K Sell
1,203
-704
-37% -$210K ﹤0.01% 719
2025
Q1
$588K Buy
1,907
+477
+33% +$163K 0.01% 628
2024
Q4
$505K Buy
1,430
+54
+4% +$19.8K 0.01% 567
2024
Q3
$493K Sell
1,376
-20
-1% -$6.76K 0.01% 591
2024
Q2
$445K Buy
1,396
+384
+38% +$102K 0.01% 606
2024
Q1
$232K Buy
1,012
+6
+0.6% +$1.35K ﹤0.01% 872
2023
Q4
$221K Buy
1,006
+44
+5% +$10.1K ﹤0.01% 848
2023
Q3
$217K Sell
962
-9
-0.9% -$2.07K ﹤0.01% 666
2023
Q2
$214K Buy
+971
New +$215K ﹤0.01% 690

Other funds holding UTHR